Competitive Technologies, Inc. Provides Additional Information for FDA 510(k) Approval
FAIRFIELD, Conn., Oct. 20, 2008 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Alternext US:CTT) (AMEX:CTT) announced today that it has provided additional information to the FDA regarding CTT's pain management therapy device. CTT is working with the FDA on the application for 510(k) medical device authorization for U.S. sales of CTT's device.